Skip to main content
SpringerLink
Log in

A prospective study of the use of111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake

  • Original Articles
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

This prospective study of radioimmunoscintigraphy using111 In-labelled, C46, a monoclonal antibody against carcino embryonic antigen, CEA, was undertaken in 23 patients with colorectal cancer, 18 with primary carcinomas, 3 with recurrences and 2 with metastases. A sensitivity of 95% and an accuracy of 91% was found. New observations through the use of two administered doses of antibody and the analysis of surgical specimens showed that for the low dose of antibody (average 0.76 mg) tumour uptake was 1.14×10−2% of the injected dose per gram, whereas on the higher dose (average 4.67 mg) the average tumour uptake was 6.77% (same units)p<0.01. Thus a six-fold increase of antibody caused a sixfold increase in tumour uptake, but no change was seen in the tumour to mucosa ratio 4.8±0.5 (low dose) and 4.0±1.0 (high dose). A further observation was that well and moderately differentiated tumours took up about four times more than poorly differentiated tumours (p<0.05). It was also found that tumour free lymph nodes had a six-fold greater uptake than tumour involved nodes (p<0.05) confirming other work with anti-CEA monoclonal antibody. In conclusion, although biological factors influence its efficacy,111In labelled C46 anti-CEA is a suitable radiopharmaceutical for the radioimmunoscintigraphy of colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldenberg DM, Kim EE, Deland FH, Benne HS, Primus FJ (1980) Radioimmunodetection of cancer with radioactive antibodies to carcino-embryonic antigen. Cancer Res 40:2984–2992

    Google Scholar 

  2. Epenetos AA, Britton KE, Mather S, Granowska M, Nimmon CC, Hawkins LA, Shepherd J, Taylor Papadimitriou J, Durbin H, Malpas JS, Bodmer W (1982) Targetting of Iodine-123 labelled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet ii:999–1004

    Google Scholar 

  3. Fairweather DS, Bradwell AR, Dykes PW, Vaughan AT, Watson-James SF, Chandler S (1983) Improved tumour localisation using Indium-111 labelled antibodies. Br Med J 287:167–170

    Google Scholar 

  4. Wahl RL, Parker CW, Philpott G (1983) Improved radioimaging and tumour localisation with monoclonal F(ab′)2. J Nucl Med 24:316–325

    Google Scholar 

  5. Siccardi AG, Buraggi GL, Callegaro L, Mariani G, Natali PG, Abbati A, Bestagno M, Caputo V, Mansi L, Ferrone S (1986) Multicentre study of immunoscintigraphy with radiolabelled monoclonal antibodies in patients with melanoma. Cancer Res 46:4817–4822

    Google Scholar 

  6. Granowska M, Britton KE, Shepherd JH, Nimmon CC, Mather S, Ward B, Osborne RJ, Slevin ML (1986) A prospective study of 123-I labelled monoclonal antibody imaging in ovarian cancer. J Clin Oncol 4:730–736

    Google Scholar 

  7. Dukes CE (1932) The classification of cancer of the rectum. J Pathol Bact 35:323–332

    Google Scholar 

  8. Mach JP, Carrel S, Forni M, Ritschard J, Donath A, Alberto P (1980) Tumour localisation of radio-labelled antibodies against Carcino-embryonic antigen in patients with carcinoma. New Engl J Med 303:5–10

    Google Scholar 

  9. Mach JP, Chatal JF, Lumbroso JD, Bucheggar F, Forni M, Ritschard J, Berche C, Douillard JY, Carrel S, Herlyn M, Steplewski X, Kaprowski H (1983) Tumour localisation of radiolabelled antibodies against colon cancer. Cancer Res 43:5593–5600

    Google Scholar 

  10. Chatal JF, Saccavini JC, Furnoleau P, Douillard JY, Curtel C, Kramer M, Le Mevel B, Koprowski H (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25:307–314

    Google Scholar 

  11. Shively JE, Beatty JE (1985) CEA related antigens: molecular biology and clinical significance. Crit Rev Oncol Haematol 2:355–399

    Google Scholar 

  12. Granowska M, Jass JR, Northover JMA, Britton KE, Bomanji J, Nimmon CC, Bingham L, Todd IP (1986) Radioimmunoscintigraphy, RIS: Practice and tumour uptake in colorectal and ovarian cancer. J Nucl Med 27:881 (Abs)

    Google Scholar 

  13. Granowska M, Britton KE, Jass JR, Northover JMA, Nimmon CC, Bingham L, Todd IP (1986) Quantitation of tumour specific uptake and kinetics after radioimmunoscintigraphy with 111-In-anticarcino embryonic antigen, CEA, monoclonal antibody in colorectal cancer. Nuklearmedizin 25:A44

    Google Scholar 

  14. Armitage NC, Perkins AC, Durrant LG, Ellis IO, Ballantyne KC, Harrison RC, Riley AML, Robins RA, Wastie ML, Hardcastle JD (1986) In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcino embryonic antigen. Br J Surg 73:965–969

    Google Scholar 

  15. Graham RM, McKee PH, Chapman DV, Richardson TC, Stokoe MR, Heyderman E (1985) Intercellular canaliculi in eccrine sweat glands: an immuno peroxidase study. Br J Dermatol 112:397–403

    Google Scholar 

  16. Begent RHJ (1986) Working party on the clinical use of antibodies: operations manual. Br J Cancer 54:557–568

    Google Scholar 

  17. Hnatovitch DH, Layne WW, Childs RL (1983) Radioactive labelling of antibody: a simple and efficient method. Science 220:613–615

    Google Scholar 

  18. Day DW, Morson BC (1978) The adenoma carcinoma sequence. In: Morson BC (ed) The pathogenesis of colorectal cancer. WB Saunders, Philadelphia, pp 48–61

    Google Scholar 

  19. Armitage NC, Perkins AC, Pimm MV, Wastie ML, Baldwin RW, Hardcastle JD (1985) Imaging of primary and metastatic colorectal cancer using an 111-In labelled antitumour monoclonal antibody (791T/36). Nucl Med Commun 6:623–631

    Google Scholar 

  20. Beatty JD, Duda RB, Williams L, Sheibani K, Paxton RJ, Beatty BG, Philben VJ, Werner JL, Shively JE, Vlahos WG, Kokal WA, Riihimaki DU, Terz JJ, Wagman LD (1986) Preoperative imaging of colorectal carcinoma with 111-In-labelled anticarcino embryonic antigen monoclonal antibody. Cancer Res 46:6494–6502

    Google Scholar 

  21. Potomski J, Harlozinska A, Starcyk H (1979) Correlation between the immunohistochemical localisation of carcinoembryonic antigen, CEA, and histological estimation of carcinomas, normal mucosa and lymph nodes of the digestive tract in humans. Arch Immunol Ther Exp 27:177–186

    Google Scholar 

  22. Granowska M, Britton KE (1986) A strategic approach to radioimmunoscintigraphy in ovarian and colorectal cancer. In: Hofer R, Bergmann H (eds) Radioaktive Isotope in Klinik und Forschung, Band 17 (I). H Egermann; Wien, pp 377–381

    Google Scholar 

  23. Spurr NK, Durbin H, Sheer D, Parkar M, Bobrow L, Bodmer WF (1986) Characterisation and chromosomal assignment of the gene MIC 18 encoding the human cell surface antigen defined by the monoclonal antibody AUA-1. Int J Cancer 38:631–636

    Google Scholar 

  24. Bomanji J, Granowska M, Britton KE, Northover JMA (1987) Pelvic lymphoimmunoscintigraphy in colorectal cancer (unpublished)

  25. Salvatore M, Lastoria S, Mansi L, Renda A, Colcher D, Schlom J, Larson SM, Callegaro L (1986) A prospective study of recurrence in colon cancer with I-131 B72.3 monoclonal antibody. J Nucl Med 6:1023 (Abstract)

    Google Scholar 

  26. Colcher D, Esteban JM, Corrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, Larson SM, Schlom J (1987) Quantitative analyses of selective radiolabelled monoclonal antibody localisation in metastatic lesions of colorectal cancer patients. Cancer Res 47:1185–1189

    Google Scholar 

  27. Carrasquillo JA, Sugarbaker P, Colcher D, Reynolds JC, Esteban J, Bryant G, Keenan AM, Perentesis P, Yokoyama K, Simpson DE, Ferroni P, Forkas R, Schlom J, Larson SM (1988) Radioimmunoscintigraphy of colon cancer with Iodine 131-labelled B72.3 monoclonal antibody. J Nucl Med 29:1022–1030

    Google Scholar 

  28. Richman PI, Bodmer WF (1987) Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterisation. Int J Cancer 39:317–328

    Google Scholar 

  29. Go VLW (1976) Carcinoembryonic antigen clinical application. Cancer 37:562–566

    Google Scholar 

  30. Moshakis V, Omerod MG, Westwood JN, Imrie S, Neville AM (1982) The site of binding of anti CEA antibodies to CEA in vivo: An immunocytochemical and autoradiographic approach. Brit J Cancer 46:18–21

    Google Scholar 

  31. Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122:467–481

    Google Scholar 

  32. Deland FM, Kim EE, Goldenberg DM (1980) Lymphoscintigraphy with radionuclide labelled antibodies to carcinoembryonic antigen. Cancer Res 40:2997–3000

    Google Scholar 

  33. Bale WF, Contreras MA, Grady ED (1980) Factors influencing localisation of labelled antibodies in tumours. Cancer Res 40:2065–2972

    Google Scholar 

  34. Duran-Reynals F (1939) Studies on the localisation of Dye and Foreign proteins in normal and malignant tissues. Am J Cancer 35:98–107

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imperial Cancer Research Fund Unit, St. Mark's Hospital, London, UK

    M. Granowska, J. R. Jass, K. E. Britton & J. M. A. Northover

Authors
  1. M. Granowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Jass
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. E. Britton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. M. A. Northover
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Granowska, M., Jass, J.R., Britton, K.E. et al. A prospective study of the use of111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorect Dis 4, 97–108 (1989). https://doi.org/10.1007/BF01646868

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01646868

Keywords

Search

Navigation